Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Hoffmann

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Pharmacogenomics|March 31, 2010
Prospective association of dopamine-related polymorphisms with smoking cessation in general careLutz P Breitling, Dorothee Twardella, Michael M Hoffmann, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Effect of fluvastatin slow-release on low density lipoprotein (LDL) subfractions in patients with type 2 diabetes mellitus: baseline LDL profile determines specific mode of actionKarl Winkler, Claudia Abletshauser, Michael M Hoffmann, et al.
Indian Journal of Pediatrics|May 31, 2020
Lipoprotein Lipase DeficiencyShwetha Kuthiroly, Dhanya Yesodharan, Natasha Radhakrishnan, et al.
Journal of Lipid Research|March 16, 2010
The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortalityGuenther Silbernagel, Guenter Fauler, Michael M Hoffmann, et al.
Hypertension in Pregnancy|September 17, 2004
Transient remnant removal disease in acute fatty liver of pregnancyBirgit Wetzka, Michael M Hoffmann, Isolde Friedrich, et al.
Clinical Chemistry|March 1, 2007
The -50G>T polymorphism in the promoter of the CYP2J2 gene in coronary heart disease: the Ludwigshafen Risk and Cardiovascular Health studyMichael M Hoffmann, Peter Bugert, Ursula Seelhorst, et al.
Journal of the American College of Cardiology|July 10, 2002
CD14 C(-260)-->T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery diseaseWolfgang Koenig, Natalie Khuseyinova, Michael M Hoffmann, et al.
Journal of Hypertension|December 23, 2004
Association analysis of the polymorphism T1128C in the signal peptide of neuropeptide Y in a Swedish hypertensive populationWilfried Renner, Tanja Grammer, Michael M Hoffmann, et al.
British Journal of Clinical Pharmacology|July 17, 2004
Endothelial venodilator response in carriers of genetic polymorphisms involved in NO synthesis and degradationRuth Fricker, Christiane Hesse, Johanna Weiss, et al.
Atherosclerosis|November 8, 2011
CRP and CD14 polymorphisms correlate with coronary plaque volume in patients with coronary artery disease--IVUS substudy of the ENCORE trialsMatthias Hermann, Dieter Fischer, Michael M Hoffmann, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Pharmacogenomics|March 31, 2010
Prospective association of dopamine-related polymorphisms with smoking cessation in general careLutz P Breitling, Dorothee Twardella, Michael M Hoffmann, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Effect of fluvastatin slow-release on low density lipoprotein (LDL) subfractions in patients with type 2 diabetes mellitus: baseline LDL profile determines specific mode of actionKarl Winkler, Claudia Abletshauser, Michael M Hoffmann, et al.
Indian Journal of Pediatrics|May 31, 2020
Lipoprotein Lipase DeficiencyShwetha Kuthiroly, Dhanya Yesodharan, Natasha Radhakrishnan, et al.
Journal of Lipid Research|March 16, 2010
The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortalityGuenther Silbernagel, Guenter Fauler, Michael M Hoffmann, et al.
Hypertension in Pregnancy|September 17, 2004
Transient remnant removal disease in acute fatty liver of pregnancyBirgit Wetzka, Michael M Hoffmann, Isolde Friedrich, et al.
Clinical Chemistry|March 1, 2007
The -50G>T polymorphism in the promoter of the CYP2J2 gene in coronary heart disease: the Ludwigshafen Risk and Cardiovascular Health studyMichael M Hoffmann, Peter Bugert, Ursula Seelhorst, et al.
Journal of the American College of Cardiology|July 10, 2002
CD14 C(-260)-->T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery diseaseWolfgang Koenig, Natalie Khuseyinova, Michael M Hoffmann, et al.
Journal of Hypertension|December 23, 2004
Association analysis of the polymorphism T1128C in the signal peptide of neuropeptide Y in a Swedish hypertensive populationWilfried Renner, Tanja Grammer, Michael M Hoffmann, et al.
British Journal of Clinical Pharmacology|July 17, 2004
Endothelial venodilator response in carriers of genetic polymorphisms involved in NO synthesis and degradationRuth Fricker, Christiane Hesse, Johanna Weiss, et al.
Atherosclerosis|November 8, 2011
CRP and CD14 polymorphisms correlate with coronary plaque volume in patients with coronary artery disease--IVUS substudy of the ENCORE trialsMatthias Hermann, Dieter Fischer, Michael M Hoffmann, et al.
Pageof 10